TrialTheranostics2020

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids.

David de Gonzalo-Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.